APE fundamentals
An in-depth look to ADDEX THERAPEUTICS LTD operating, investing, and financing activities
APE free cash flow for Q4 23 is -666.59 k EUR. For 2023, APE free cash flow was -8.56 M EUR and operating cash flow was -8.56 M EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM